Sophie Hébrard
Inserm · 21 works · 2,195 citations · h-index 11
Top works
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- Srf-Dependent Paracrine Signals Produced by Myofibers Control Satellite Cell-Mediated Skeletal Muscle Hypertrophy
- AMP-activated Protein Kinase α2 Subunit Is Required for the Preservation of Hepatic Insulin Sensitivity by n-3 Polyunsaturated Fatty Acids
- RETRACTED: Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
- Head-down tilt bed rest and immune responses
- The AMPKyl subunit plays an essential role in erythrocyte membrane elasticity, and its genetic inactivation induces splenomegaly and anemia
- Increased FAT/CD36 Cycling and Lipid Accumulation in Myotubes Derived from Obese Type 2 Diabetic Patients
- Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients
- Conditional inactivation of the murine serum response factor in the pancreas leads to severe pancreatitis
- The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
- Erratum: The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
- Srf : un acteur clé de l’hypertrophie du muscle squelettique
- O32 Absence d’effet direct de l’AMPK sur la production hépatique de glucose
- O31 Mécanisme d’inhibition de la production hépatique de glucose par la metformine
- O32 Absence deffet direct de lAMPK sur la production hpatique de glucose
- O74 L’adiponectine inhibe la production de glucose hépatique par un mécanisme indépendant de la voie LKB1-AMPK